RecruitingNCT05462574
Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)
Studying Heritable pulmonary arterial hypertension
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Vanderbilt University Medical Center
- Principal Investigator
- Evan Brittain, MD, MSCIVanderbilt University Medical Center
- Intervention
- No Intervention(other)
- Enrollment
- 75 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2027
Study locations (1)
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05462574 on ClinicalTrials.govOther trials for Heritable pulmonary arterial hypertension
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06850792imprOving Adherence to Pulmonary artErial hyperteNsion Treatment With teLemedicIne and patieNt guidaNceUniversity of Sao Paulo General Hospital
- ACTIVE NOT RECRUITINGNCT06587074Features of the Clinical Course and Prognosis in Patients With Idiopathic Pulmonary Hypertension When Using Modern Strategies of Specific TherapyRussian Cardiology Research and Production Center
See all trials for Heritable pulmonary arterial hypertension →